Arthritis Research & Therapy

official impact factor 4.36

Meeting report

The 3rd International Meeting on Gene Therapy in Rheumatology and Orthopaedics

Christopher H Evans1*, Steven C Ghivizzani2, Elvire Gouze2, John J Rediske3, Edward M Schwarz4 and Paul D Robbins5

Author Affiliations

1 Center for Molecular Orthopaedics, Harvard Medical School, Boston, Massachusetts, USA

2 Department of Orthopaedics and Rehabilitation, University of Florida College of Medicine, Gainesville, Florida, USA

3 Novartis Inc., East Hanover, New Jersy, USA

4 Department of Orthopaedics, University of Rochester School of Medicine, Rochester, New York, USA

5 Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

For all author emails, please log on.

Arthritis Research & Therapy 2005, 7:273-278 doi:10.1186/ar1853

Published: 28 October 2005

Abstract

The 3rd International Meeting on Gene Therapy in Rheumatology and Orthopaedics was held in Boston, Massachusetts, USA in May 2004. Keystone lectures delivered by Drs Joseph Glorioso and Inder Verma provided comprehensive, up-to-date information on all major virus vectors. Other invited speakers covered the application of gene therapy to treatment of arthritis, including the latest clinical trial in rheumatoid arthritis, as well as lupus and Sjögren's syndrome. Applications in mesenchymal stem cell biology, tissue repair, and regenerative medicine were also addressed. The field has advanced considerably since the previous meeting in this series, and further clinical trials seem likely.